Higher absolute lymphocyte counts predict lower mortality from early-stage triple-negative breast cancer
A Afghahi, N Purington, SS Han, M Desai… - Clinical Cancer …, 2018 - AACR
Purpose: Tumor-infiltrating lymphocytes (TIL) in pretreatment biopsies are associated with
improved survival in triple-negative breast cancer (TNBC). We investigated whether higher …
improved survival in triple-negative breast cancer (TNBC). We investigated whether higher …
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer
DA Patel, J Xi, J Luo, B Hassan, S Thomas… - Breast cancer research …, 2019 - Springer
Purpose Peripheral blood lymphopenia and elevated neutrophil-to-lymphocyte ratio (NLR)
have been associated with poor outcomes in various malignancies. However, existing …
have been associated with poor outcomes in various malignancies. However, existing …
[HTML][HTML] Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy
C Herrero-Vicent, A Guerrero, J Gavilá… - …, 2017 - ncbi.nlm.nih.gov
Results A total of 164 TNBC patients were treated with NAC and surgery. The main patients'
characteristics are listed in Table 1. We identify different pathological complete response to …
characteristics are listed in Table 1. We identify different pathological complete response to …
[HTML][HTML] Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after …
SJ Luen, R Salgado, MV Dieci, A Vingiani… - Annals of …, 2019 - Elsevier
Background For primary triple-negative breast cancer (TNBC) treated with neoadjuvant
chemotherapy (NAC), higher pretreatment tumor-infiltrating lymphocytes (TILs) correlates …
chemotherapy (NAC), higher pretreatment tumor-infiltrating lymphocytes (TILs) correlates …
[HTML][HTML] Platelet-to-lymphocyte ratio is associated with favorable response to neoadjuvant chemotherapy in triple negative breast cancer: a study on 120 patients
S Lusho, X Durando, MA Mouret-Reynier… - Frontiers in …, 2021 - frontiersin.org
IntroductionTriple negative breast cancer (TNBC) is highly heterogeneous, but still most of
the patients are treated by the anthracycline/taxane-based neoadjuvant therapy (NACT) …
the patients are treated by the anthracycline/taxane-based neoadjuvant therapy (NACT) …
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
AI Hida, T Watanabe, Y Sagara, M Kashiwaba… - Breast cancer research …, 2019 - Springer
Purpose High-density tumor-infiltrating lymphocytes (TILs) are a prognostic marker for triple-
negative breast cancer (TNBC). However, lymphocytic infiltration is heterogeneous in its …
negative breast cancer (TNBC). However, lymphocytic infiltration is heterogeneous in its …
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical …
The purpose of this study was to assess the prognostic and predictive value of tumor-
infiltrating lymphocytes (TILs) in the triple-negative breast cancer (TNBC) cohort of the phase …
infiltrating lymphocytes (TILs) in the triple-negative breast cancer (TNBC) cohort of the phase …
[HTML][HTML] Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant …
M Miyashita, H Sasano, K Tamaki, H Hirakawa… - Breast Cancer …, 2015 - Springer
Introduction The status of tumor-infiltrating lymphocytes (TILs) has been recently proposed to
predict clinical outcome of patients with breast cancer. We therefore studied the prognostic …
predict clinical outcome of patients with breast cancer. We therefore studied the prognostic …
[HTML][HTML] Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer
G Pruneri, A Vingiani, V Bagnardi, N Rotmensz… - Annals of oncology, 2016 - Elsevier
Background Although tumor-infiltrating lymphocytes (TILs) have been associated with a
favorable prognosis in triple-negative breast cancer (TNBC) patients, this marker is not …
favorable prognosis in triple-negative breast cancer (TNBC) patients, this marker is not …
159O Prognostic value of tumour infiltrating lymphocytes in young triple negative breast cancer patients who did not receive adjuvant systemic treatment; by the …
VMT De Jong, Y Wang, M Opdam… - Annals of …, 2020 - annalsofoncology.org
Background Uncertainty exists whether all young (< 40 years) patients with triple negative
breast cancer (TNBC) require (neo) adjuvant chemotherapy. Increasing stromal tumour …
breast cancer (TNBC) require (neo) adjuvant chemotherapy. Increasing stromal tumour …
相关搜索
- breast cancer neoadjuvant chemotherapy
- lymphocyte counts lower mortality
- breast cancer lymphocyte counts
- breast cancer lower mortality
- breast cancer survival in patients
- breast cancer residual tumors
- breast cancer chemotherapeutic effect
- breast cancer clinical validity
- breast cancer immune phenotype
- breast cancer favorable response
- breast cancer prognostic significance
- breast cancer lymphocytes tils
- breast cancer lymphocytes analysis
- breast cancer neoadjuvant therapy
- breast cancer predictor of survival